Descripción del título
Monografía
monografia Rebiun36210245 https://catalogo.rebiun.org/rebiun/record/Rebiun36210245 m o d | cr cn||||||||| 030612s2003 dcu ob 001 0 eng d 1-280-08548-7 9786610085484 0-585-49593-9 10.1596/978-0-8213-5570-1 CBUC 991010881536106709 UPVA 997912642503706 UPCT u109392 MiAaPQ eng rda pn MiAaPQ MiAaPQ eng d------ 338.4/33621/091724 21 Health economics in development edited by Philip Musgrove 1st ed Washington, DC World Bank 2003 Washington, DC Washington, DC World Bank xviii, 433 pages illustrations 23 cm xviii, 433 pages Text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Health, nutrition, and population series Bibliographic Level Mode of Issuance: Monograph Includes bibliographical references and index Intro -- Contents -- Foreword -- Acknowledgments -- Introduction -- 1 What Is the Minimum a Doctor Should Know about Health Economics? -- 2 Public and Private Roles in Health -- 3 The Rationale for Government Intervention in the Tobacco Market -- 4 Measurement of Equity in Health -- 5 What Should Consumers in Poor Countries Pay for Publicly-Provided Health Services? -- 6 Compensatory Finance in Health:Geographic Equity in a Federal System -- 7 An Ounce of Prevention Is Worth How Much Cure? -- 8 DALYs and Cost-Effectiveness Analysis -- 9 Criteria for Public Spending on Health Care -- 10 Cost-Effectiveness and the Socialization of Health Care -- 11 Is the Eradication of Polio in the Western Hemisphere Economically Justified? -- 12 Cost-Benefit Analysis of a Regional Vaccination System -- 13 Cost-Effective Malaria Control in Brazil -- 14 Do the Poor in Brazil Pay More for Food? -- 15 Do Brazilian Nutrition Programs Make a Difference? -- 16 Economic Aspects of Food Fortification -- 17 Malnutrition and Dietary Protein -- 18 Family Health Care Spending in Latin America -- 19 Basic Patterns in National Health Expenditure -- 20 Economic Crisis and Health Policy Response -- Index -- Tables -- I.1 Principal Differences between Health Insurance and Insurance for Nonhuman Assets -- I.2 Principal Differences and Similarities between Education and Health -- 4.1 Measures Related to Equity in Health Care, Peru, 1982: Health Care Resources and Sanitation Services -- 4.2 Measures Related to Equity in Health Care in Peru, 1984: Morbidity and Medical Attention -- 4.3 Measures Related to Equity in Health Care in Peru, 1984: Consultations, Hospitalizations and Expenditures -- 4.4 Measures Related to Equity In Health Care in Peru, 1984: Vaccination Coverage (%) of Children Under 5 11.1 Costs and Benefits Associated with Polio Eradication During a Successful Five-Year Campaign and an Ensuing Ten-Year Maintenance Period,Assuming all Polio Victims are Treated -- 11.2 Costs and Benefits Associated with Polio Eradication During a Successful Five-Year Campaign and Ten-Year Maintenance Period,Assuming only a Fraction of all Polio Victims are Treated -- 11.3 A Comparison of Ten-Year Costs and Results of Two Hypothetical Polio Eradication Campaigns, One Immediate and One Delaye -- 12.1 Cost of SIREVA, by Year, in Constant US -- 12.2 The Projected Numbers of Individuals to be Vaccinated, by Target Disease and Year -- 12.3 Total Discounted Numbers of Disease Cases Prevented, Deaths Prevented with Treatment of all Cases, and Deaths Prevented -- 12.4 The Estimated Cost of Treatment (in Constant US), Probability of Preventing One Case, and Implied Maximum Cost of Vacci -- 12.5 The Average Implied Maximum Cost of Vaccination (in Constant US) Derived from the Number of Individuals Vaccinated, Tre -- 12.6 Implied Minimum Benefit per Case Prevented and per Death Prevented as a Function of the Cost of Vaccination, without Con -- 12.7 The Effects of Adjusting for the Delay between Vaccination and Disease Onset upon the Implied Maximum Cost of Vaccination and upon the Implied Minimum Benefits of Preventing a Disease Case,in Constant US -- 13.1 Population (Millions) and Number of Municipalities by Risk of Malaria Transmission, Based on API, 1988-1995 -- 13.2 Estimated Cases, Lives and DALYs Saved by Preventing and Treating Malaria, 1989-1996. Cases Prevented and Cases Reported -- 13.3 Estimated Cases, Lives and DALYs Saved by Preventing and Treating Malaria, 1989-1996. Conversion of Savings in Lives and -- 13.4 Costs of the Malaria Control Program, 1989-1996 (Thousands of 1996 US, Discounted at 3% for 1989-1995) and Cases Treate 13.5 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1992, 1993-1996 (Discounted Present Values). Most Plausible As -- 13.6 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1992, 1993-1996 and 1989-1996 (Discounted Present Values). Sen -- 13.7 Cost-Effectiveness of Saving Lives from Falciparum, 1989-1996 (Discounted Present Values). Sensitivity Analysis: Untreat -- 13.8 Effects of Reduced Incidence, Severity and Lethality on Mortality Reduction -- 14.1 Sample Size (Number of Retailers) by City Size, Type of Neighborhood, and Type of Establishment -- 14.2 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Municipality for Small Retailers Not Affiliated with Sub -- 14.3 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by City Size for Small Retailers Not Affiliated with Subsid -- 14.4 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Type of Establishment: Three Metropolitan Areas -- 14.5 Mean Prices, in June 1985 Cruzeiros, of Selected Basic Foods by Type of Establishment: Six Medium-Size Cities -- 14.6 Prices as Functions of City, Neighborhood, and Type of Establishment:Regression Coefficients -- 14.7 Quadratic Regression of Price versus Quantity for Fractional Purchases of Eight Basic Foods, in all Establishments and S -- 15.1 Principal Characteristics of Four Nutrition Programs, Brazil, 1974-86 -- 15.2 Aggregate Estimates for Physical Distribution of Foods, Total Cost, and Total Public Expenditure at Constant June 1984 P -- 15.3 PINS: Number of Families Entitled to Purchase Subsidized Food ("Participating ") and Number of Families that Actually Bo -- 15.4 Changes Observed in Weight for Age in Children Participating in the PNS in Two Municipalities in São Paulo, March 1980-A -- 15.5 PNS, PCA, and PINS: Cost Structure in Percentage Terms (Data for One or More Years between 1978 and 1980) 15.6 Recife, Pernambuco: Subsidy Level (Percentage) and PROAB Prices (Percentage Difference from Supermarket Price, with and -- 15.7 Actual Transfer of the PROAB Subsidy to the Consumer, in Relation to Minimarket Prices, Recife, March-August 1984 -- 15.8 Changes Observed in Children Participating in the PCA, PNS, or PINS, According to Anthropometric Criterion, Duration of -- 15.9 Changes in Weight for Age in Initially Underweight Children Participating in the PNS or PINS, by Program, Initial Age, a -- 15.10 Number of Children Initially Aged Under Six Participating in the PINS, According to Initial and Final Nutritional Statu -- 15.11 Changes in Weight for Age Observed in Children Initially Aged Under 12 Months, Participating in the PINS, According to -- 15.12 Changes Observed in Children Participating in the PNS, Initially Aged between 6 and 12 Months Old, According to Anthrop -- 15.13 Weights of Live Births to Mothers who were Beneficiaries of the PNS and PCA, Compared with Non-Beneficiaries -- 17.1 Variables for Urban China in 1979 -- 17.2 Determinants of the Height and Weight of Young Adults (Age 18 -25 Years) in Urban China in 1979 -- 17.3 Variables for Rural Chinese Counties in 1983 -- 17.4 Determinants of Adult Height and Weight in Rural Chinese Counties in 1983 -- 17.5 Variables for International Comparisons -- 17.6 Determinants of Adult Male Height (41 Populations in 40 Countries) and Adult Female Height (33 Populations in 32 Countri -- 18.1 Elasticities with Respect to Total Expenditure -- 18.2 Estimated Total Family Expenditure per Person and Private Health Care Expenditure, by Quartile 1 (low) to 4 (high) of To -- 18.3 Mean Values of Total Family Expenditure (PCE) and Private Health Care Spending (HEA), within Each of Nine Classes of Tot 18.4 Brazil, 1974: Private Family Health Care Spending as a Function of Total Family Expenditure, Region and Metropolitan/Oth -- 18.5 Mean Values of Private Family Expenditure on Drugs and Medicines and on Hospitalization and Surgery, within Each of Nine -- 19.1 National Health Accounts Estimates for 191 WHO Member States for 1997, Revised Data as of 31 May 2001 -- 19.2 Countries Grouped by WHO Region, Mortality Stratum, and GDP per Capita -- 19.3 Regression Statistics for Health Expenditure as a Percentage of Gross Domestic Product -- 19.4 Regression Statistics for Out of Pocket Payments as a Percentage of Total Health Expenditure -- 19.5 Regression Statistics for Public Health Expenditure as a Percentage of Total Health Expenditure -- 19.6 Regression Statistics for Public Health Expenditure as a Percentage of Total Public Expenditure -- 19.7 Regression Statistics for Out-of-Pocket Payments per Capita as a Function of Income per Capita -- 19.8 Regression Statistics for Total Health Expenditure per Capita as a Function of Income per Capita -- 19.9 Regression Statistics for Total Public Expenditure per Capita as a Function of Income per Capita -- 20.1 Indices of Public Expenditures on Health (Central Government or Total Public Sector) in Thirteen Latin American and Cari -- Figures -- I.1 Decision Flowchart, Sources of Health Financing -- 2.1 Three Domains of Health Care -- 2.2 Need, Demand and Supply for Health Care -- 2.3A Appropriate Use of the Instruments of Public Intervention in Health Care -- 2.3B Typically Inappropriate Use of the Instruments of Public Intervention in Health Care -- 4.1 Schematic Stages of Illness or Accident, Treatment and Outcome -- 4.2 Lorenz Curves of Inequality of the Distribution of Physicians Rrelative to Population (by Department) and of Ministry of -- 5.1 Demand for Medical Care as a Function of Income and Prices 7.1 Marginal Costs of a Curative and a Preventive Intervention, when Prevention is Always Cheaper and Everyone Receives One I. English Medical economics- Developing countries Public health- Developing countries Musgrove, Philip 0-8213-5570-8 Health, nutrition, and population series